Cargando…
Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma
LESSONS LEARNED: Despite the initial optimism for using immune checkpoint inhibition in the treatment of multiple myeloma, subsequent clinical studies have been disappointing. Preclinical studies have suggested that priming the immune system with various modalities in addition to checkpoint inhibiti...
Autores principales: | Kazandjian, Dickran, Dew, Alexander, Hill, Elizabeth, Ramirez, Elizabeth Gil, Morrison, Candis, Mena, Esther, Lindenberg, Liza, Yuan, Constance, Maric, Irina, Wang, Hao‐Wei, Calvo, Katherine, Dulau‐Florea, Alina, Roswarski, Joseph, Emanuel, Michael, Braylan, Raul, Turkbey, Baris, Choyke, Peter, Camphausen, Kevin, Stetler‐Stevenson, Maryalice, Steinberg, Seth M., Figg, William D., C. Jones, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018315/ https://www.ncbi.nlm.nih.gov/pubmed/33554406 http://dx.doi.org/10.1002/onco.13712 |
Ejemplares similares
-
Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma
por: Li, Haoran, et al.
Publicado: (2023) -
Hypofractionated Stereotactic Re-irradiation and Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results
por: Pouessel, Damien, et al.
Publicado: (2023) -
Black Patients with Metastatic Castrate-Resistant Prostate Cancer Have a Shorter Time Interval Between PSA and Clinical Progression on Novel Hormonal Therapies plus Avelumab
por: Hawkins, Charlotte (Manogue), et al.
Publicado: (2022) -
A Phase 1 Trial of Highly Conformal, Hypofractionated Postprostatectomy Radiation Therapy
por: Patel, Krishnan R., et al.
Publicado: (2022) -
The Role of MRI in Prostate Cancer Active Surveillance
por: Johnson, Linda M., et al.
Publicado: (2014)